The global neuralgia treatment market size is expected to reach USD 2.8 billion by 2027, expanding at a CAGR of 6.0%, according to a new report by Grand View Research, Inc. The rising geriatric population, increasing incidence of trigeminal neuralgia, and the growing prevalence of diabetes are the key factors driving the market. Neuralgia is a burning, stabbing, and severe pain due to a damaged or irritated nerve.
The
chronic pain in the nerves can occur due to various factors such as infection,
diabetes, aging, multiple sclerosis, or any similar disorders that damage the
myelin sheath protecting certain nerves. Tumor compressing the trigeminal nerve
can also cause the disorder. The prevalence of chronic pain in the trigeminal
nerve increases with the aging population. According to the estimates published
by the WHO, the geriatric population is anticipated to rise from 900.0 million
in 2015 to 2.0 billion in 2050. The geriatric population is prone to many
diseases such as diabetes and trigeminal neuralgia.
As
per the American Association of Neuromuscular and Electrodiagnostic Medicine,
the disorder usually affects the population aged 50 years or older. It also
reported that women are more prone to trigeminal neuralgia than men. As per the
study, The Patient’s Journey Through Trigeminal Neuralgia published
by the International Association for The Study of Pain (IASP), the incidence
rate of the disorder in the general population is 3.4 to 5.9 per 100,000
population. It also reported that the incidence rate is comparatively higher in
the geriatric population. Such factors are expected to boost market growth over
the forecast period. Stereotactic radiosurgery and microvascular decompression
are the two most common procedures being adopted to treat the disorder.
Full Research Report On Neuralgia Treatment Market Visit Here:
https://www.grandviewresearch.com/industry-analysis/neuralgia-treatment-market
Neuralgia Treatment
Market Report Highlights
- On the basis of treatment,
the surgery segment held the largest market share in 2019 owing to rising
awareness regarding various treatment options and the high cost of
surgeries
- The surgery segment has been
further sub-segmented into Radiofrequency Thermal Lesioning, Stereotactic
Radiosurgery, Microvascular Decompression, and others
- The ambulatory surgery center
segment is anticipated to witness the fastest growth over the forecast
period owing to the rising demand for a reduced hospital stay
- In North America, the market
held the largest revenue share in 2019 owing to the presence of key
players in the region.
Request a free Sample Copy of the
Report @ https://www.grandviewresearch.com/industry-analysis/neuralgia-treatment-market/request/rs1
Neuralgia Treatment
Market Segmentation
Grand View Research has segmented
the global neuralgia treatment market on the basis of treatment, end-use, and
region:
Neuralgia Treatment
Outlook (Revenue, USD Million, 2016 - 2027)
- Drug Based
- Anticonvulsant Medicines
- Tricyclic Antidepressants
- Surgery
- Radiofrequency Thermal
Lesioning
- Stereotactic Radiosurgery
- Microvascular Decompression
- Others
Neuralgia Treatment
End-use Outlook (Revenue, USD Million, 2016 - 2027)
- Hospital & Clinics
- Ambulatory Surgery Centers
- Others
Neuralgia Treatment
Regional Outlook (Revenue, USD Million, 2016 - 2027)
- North America
- The U.S.
- Canada
- Europe
- The U.K.
- Germany
- Asia Pacific
- Japan
- China
- Latin America
- Brazil
- Mexico
- MEA
- South Africa
- Saudi Arabia
List of Key
Players of Neuralgia Treatment Market
- GlaxoSmithKline PLC
- Pfizer Inc.
- Novartis AG
- Biogen
- Cadila Healthcare Limited
- Lundbeck Pharmaceuticals LLC
About Grand View Research
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco. The
company provides syndicated research reports, customized research reports, and
consulting services. To help clients make informed business decisions, we offer
market intelligence studies ensuring relevant and fact-based research across a
range of industries, from technology to chemicals, materials and healthcare.
For more info visit @ https://www.grandviewresearch.com
No comments:
Post a Comment